INVO Fertility, Inc. (IVF) - Total Assets
Based on the latest financial reports, INVO Fertility, Inc. (IVF) holds total assets worth $18.83 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore INVO Fertility, Inc. (IVF) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
INVO Fertility, Inc. - Total Assets Trend (2006–2024)
This chart illustrates how INVO Fertility, Inc.'s total assets have evolved over time, based on quarterly financial data. See IVF book value for net asset value and shareholders' equity analysis.
INVO Fertility, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
INVO Fertility, Inc.'s total assets of $18.83 Million consist of 2.8% current assets and 97.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.6% |
| Accounts Receivable | $174.88K | 0.4% |
| Inventory | $219.76K | 0.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $18.10 Million | 39.0% |
| Goodwill | $23.54 Million | 50.7% |
Asset Composition Trend (2006–2024)
This chart illustrates how INVO Fertility, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see IVF market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INVO Fertility, Inc.'s current assets represent 2.8% of total assets in 2024, a decrease from 36.5% in 2006.
- Cash Position: Cash and equivalents constituted 1.6% of total assets in 2024, down from 36.5% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 88.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 50.7% of total assets.
INVO Fertility, Inc. Competitors by Total Assets
Key competitors of INVO Fertility, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
Novacyt
PA:ALNOV
|
France | €40.28 Million |
|
HeraMED Limited
F:1I4
|
Germany | €1.49 Million |
|
Implanet SA
PA:ALIMP
|
France | €18.45 Million |
INVO Fertility, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 0.23 | 4.61 |
| Quick Ratio | 0.10 | 0.20 | 4.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-8.11 Million | $-6.70 Million | $8.25 Million |
INVO Fertility, Inc. - Advanced Valuation Insights
This section examines the relationship between INVO Fertility, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.97 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 151.0% |
| Total Assets | $46.45 Million |
| Market Capitalization | $1.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values INVO Fertility, Inc.'s assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: INVO Fertility, Inc.'s assets grew by 151.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for INVO Fertility, Inc. (2006–2024)
The table below shows the annual total assets of INVO Fertility, Inc. from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $46.45 Million | +151.00% |
| 2023-12-31 | $18.51 Million | +398.84% |
| 2022-12-31 | $3.71 Million | -64.56% |
| 2021-12-31 | $10.47 Million | -4.39% |
| 2020-12-31 | $10.95 Million | +509.72% |
| 2019-12-31 | $1.80 Million | +130.98% |
| 2018-12-31 | $777.35K | +191.78% |
| 2017-12-31 | $266.41K | -6.92% |
| 2016-12-31 | $286.23K | -50.63% |
| 2015-12-31 | $579.79K | +436.59% |
| 2014-12-31 | $108.05K | -11.83% |
| 2013-12-31 | $122.54K | -2.18% |
| 2012-12-31 | $125.27K | -2.04% |
| 2011-12-31 | $127.88K | -29.35% |
| 2010-12-31 | $181.00K | -59.13% |
| 2009-12-31 | $442.84K | -41.85% |
| 2008-12-31 | $761.55K | +1265.48% |
| 2007-12-31 | $55.77K | +47.59% |
| 2006-12-31 | $37.79K | -- |
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body… Read more